Title: Nanomedicine Consultant, Pharmaceutical and Educational Trainer
Company: NanoMed Solution, LLC
Location: Peoria, Arizona, United States
Professor Tamer Elbayoumi (Biomi), PhD, nanomedicine consultant and pharmaceutical and educational trainer at NanoMed Solution, LLC, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in pharmaceutical sciences.
Dr. Elbayoumi is a highly respected figure in pharmaceutical sciences and nanomedicine, renowned for his pioneering work in drug delivery and therapy development. He earned a Bachelor of Pharmacy from Alexandria University in Egypt in 1999, followed by a Master of Science in biomedical sciences and a PhD in pharmaceutical sciences from Northeastern University in 2003 and 2006, respectively. Continuing his academic journey, he completed a postdoctoral fellowship at Northeastern University’s Center for Pharmaceutical Biotechnology and Nanomedicine from 2005 to 2006.
His illustrious career spans academia, industry, and research, with significant roles at esteemed organizations. Serving as a research scientist of formulation at Atrium Medical from 2006 to 2009, he transitioned to academia, becoming an assistant professor in pharmaceutical sciences at Midwestern University from 2009 to 2014 and subsequently an associate professor until 2020. Concurrently, he held the position of co-director at the Nanomedicine Center of Excellence in Translational Cancer Research at Midwestern University from 2016 to 2020.
Currently, Dr. Elbayoumi holds key positions, including chief scientific officer at NanoMed Solution, LLC, and nanomedicine consultant for pharmaceutical and educational training at CSL, previously Commonwealth Serum Laboratories, since 2020. He also serves as a professor at Midwestern University in Arizona since 2020 and as the CMC formulation and clinical pharmacology research and development lead at Nour Heart, Inc., and Nour Heart Therapeutics, LLC, a role he has held since 2009.
Throughout his career, Dr. Elbayoumi’s contributions have been notable, including founding the Nanomedicine Center of Excellence at Midwestern University. His achievements have garnered prestigious awards, such as the Outstanding Drug Delivery Award from the Controlled Release Society and fellowships from the American Cancer Society and the Royal Society of Medicine. With over 50 peer-reviewed publications and a career impact factor exceeding 200, his influence in pharmaceutical sciences is profound. Looking ahead, he remains dedicated to driving innovation in drug development and enhancing patient care through collaborative research initiatives.
For more information, please visit:
Contact Tamer Dr. Elbayoumi:
